Quick Answer
OptimizeRx Corp reported Total Assets of $176.92 million for the year ending 2025.
- OptimizeRx Corp showed an increase of +3.4% in Total Assets from 2024 to 2025.
- This data is from OptimizeRx Corp's annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $3.16 million | Q3 2011: $2.65 million | Q1 2012: $2.36 million | Q2 2012: $2.42 million | Q3 2012: $2.22 million | Q1 2013: $2.14 million | Q2 2013: $2.50 million | Q3 2013: $2.82 million | Q1 2014: $6.52 million | Q2 2014: $6.27 million | Q3 2014: $6.38 million | Q1 2015: $6.76 million | Q2 2015: $6.98 million | Q3 2015: $12.32 million | Q1 2016: $11.10 million | Q2 2016: $11.00 million | Q3 2016: $11.26 million | Q1 2017: $10.93 million | Q2 2017: $10.48 million | Q3 2017: $9.81 million | Q1 2018: $9.27 million | Q2 2018: $18.64 million | Q3 2018: $19.76 million | Q1 2019: $25.26 million | Q2 2019: $49.64 million | Q3 2019: $48.55 million | Q1 2020: $56.24 million | Q2 2020: $56.06 million | Q3 2020: $55.15 million | Q1 2021: $127.57 million | Q2 2021: $131.62 million | Q3 2021: $134.65 million | Q1 2022: $138.14 million | Q2 2022: $147.45 million | Q3 2022: $135.87 million | Q1 2023: $131.69 million | Q2 2023: $121.32 million | Q3 2023: $123.93 million | Q1 2024: $176.37 million | Q2 2024: $172.88 million | Q3 2024: $165.20 million | Q1 2025: $167.77 million | Q2 2025: $169.27 million | Q3 2025: $170.32 million.
- Over the full 16 years of available data (2010 to 2025), OptimizeRx Corp's Total Assets has grown by 4,619.5%.
- Historical annual values: Fiscal year 2025: $176.92 million | Fiscal year 2024: $171.17 million | Fiscal year 2023: $183.37 million | Fiscal year 2022: $134.65 million | Fiscal year 2021: $140.99 million | Fiscal year 2020: $60.33 million | Fiscal year 2019: $56.64 million | Fiscal year 2018: $25.05 million | Fiscal year 2017: $9.76 million | Fiscal year 2016: $11.48 million | Fiscal year 2015: $12.31 million | Fiscal year 2014: $7.03 million | Fiscal year 2013: $3.95 million | Fiscal year 2012: $2.18 million | Fiscal year 2011: $2.89 million | Fiscal year 2010: $3.75 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: